about
Challenges of drug-resistant malariaBone Regeneration from PLGA Micro-NanoparticlesSurface-enabled propulsion and control of colloidal microwheelsFormulation of nanotized curcumin and demonstration of its antimalarial efficacy.Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranosticsFormulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastomaPreparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticlesPoly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization.Cellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NFκB and ERK signaling.Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures.Supercritical fluid technology for enhanced drug delivery.Silica nanoparticles sensitize human multiple myeloma cells to snake (Walterinnesia aegyptia) venom-induced apoptosis and growth arrestThe performance of nanocarriers for transmucosal drug delivery.Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Targeting vault nanoparticles to specific cell surface receptorsMicro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivoEfficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas DiseaseBiomedical applications of functionalized fullerene-based nanomaterials.Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.Nanomaterials: applications in cancer imaging and therapy.Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy.Targeted Nanotherapies for the Treatment of Surgical Diseases.Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.Plant extracts: from encapsulation to application.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Malaria treatment using novel nano-based drug delivery systems.Snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles induce apoptosis and growth arrest in human prostate cancer cells.Potential of novel drug delivery systems in the management of topical candidiasis.Biodegradable Three-Layered Micelles and Injectable Hydrogels.Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation.Nanomedicines: a theranostic approach for hepatocellular carcinoma.Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use.Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cellsFormulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
P2860
Q21032482-3A6C9F82-FEE1-441B-B3E3-00F3648B8D10Q26778233-5AAD262B-2998-48B5-A22A-E95C91F1D236Q27336355-15151A63-C225-4E7B-B00C-69E8BFAD44E0Q30423448-B50EC947-1FFA-498E-8141-393F1DE1AAEBQ30462417-D89F77B2-7354-4DEE-9A69-935FC9DD04D7Q33642023-860AB048-A82C-424A-9062-D6277D9255A0Q33769470-37E0F796-BBDA-438D-A732-BE606F149FBEQ34065947-00E7B151-4D89-4CA1-AFA6-69624D699DB8Q34312430-FEC63AF3-8712-498E-810E-BF42FC04A158Q34482076-724EB9D1-6FE2-4E89-80DF-9E9860B25C54Q34517100-C6EC80CD-8257-4A95-A8A6-2E86B57DCE8CQ35847798-D42C1577-CF60-45BE-85EB-79907155D894Q36025624-94C42CA5-FF18-4B65-BBA7-6B1AF4330FB0Q36316895-CE82A3FD-0A6E-4A50-BACE-23888A0D052FQ36486382-22A166D1-2484-49B5-980F-C032B0DF967EQ36527739-E09F10FE-41F0-4979-99A8-E9DF0DFF7513Q36825153-253446C9-CB66-4D18-A2B8-770D4529E5E9Q36981230-FCC6A5EC-EDB7-4FCE-A564-023F56424A19Q37015849-66B741FE-F656-4BD8-8949-DBC4137F25C7Q37094289-3F67B788-5564-45B9-85DE-CF6979B1CEE0Q37176404-B80A51C2-1C18-4352-BAD2-1D91908AFAE2Q37178530-16AB9F45-287F-45BB-BEB3-36CD6F00C239Q37203890-AB5C4779-2A9F-438A-9A3A-9BF675E7CEEFQ37461946-829BBE98-E1E4-4908-91B1-2462D1D12E24Q37848104-C0915220-828D-4085-8844-255F90D04372Q37857064-26B809D3-DC70-4069-ACE2-4B102287081EQ37883474-84FA1339-DBD8-44CC-B132-D77B3EB18FFBQ38693341-F1F4606C-C666-450C-9098-C6CCDAC9F77CQ38805246-443C06C6-8035-4A70-B9F9-B380CF943EA9Q38823966-FB87EF94-70BC-440C-8F96-0D83C7DDF122Q39076542-221D2755-0ACF-495B-8452-286F459B3B58Q39122575-B9C1E065-3DD7-4E69-903D-D2D3913FEE4DQ39226388-08A6535A-56F2-4283-964D-075E788429DDQ39315981-855E12EF-7215-4942-8C00-83454EEA0D37Q39582857-14516C4A-8946-494A-A5B4-7D74781864ADQ39663529-54202C9E-7BA2-44FA-A788-6C28AAC57582Q40051560-6AAE19C4-B399-49F6-9368-F746652FAB6EQ40230892-3820D498-2090-4058-86C0-931B5005F4BBQ41892512-F211035B-C93B-47A7-AC8E-CDCAE0D105FCQ41989136-B0FC2F4A-3762-4A89-B6A1-9F6EAA0F3878
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Colloidal drug carriers: achievements and perspectives.
@ast
Colloidal drug carriers: achievements and perspectives.
@en
type
label
Colloidal drug carriers: achievements and perspectives.
@ast
Colloidal drug carriers: achievements and perspectives.
@en
prefLabel
Colloidal drug carriers: achievements and perspectives.
@ast
Colloidal drug carriers: achievements and perspectives.
@en
P356
P1476
Colloidal drug carriers: achievements and perspectives.
@en
P2093
P2888
P356
10.1007/S000180300002
P577
2003-01-01T00:00:00Z